Literature DB >> 22079192

Intrathecally synthesized IgG in multiple sclerosis cerebrospinal fluid recognizes identical epitopes over time.

Xiaoli Yu1, Mark Burgoon, Miyoko Green, Olga Barmina, Kathryn Dennison, Tiffany Pointon, Molly Davis, Don Gilden.   

Abstract

Intrathecal antibody production manifest as oligoclonal bands (OCBs) is a hallmark of multiple sclerosis (MS). Once present, OCBs can be detected in CSF throughout the lifetime of MS patients. To determine the specificity of the OCBs, we applied CSF IgG obtained from 2 consecutive lumbar punctures of 5 MS patients to screen phage-displayed random peptide libraries, and selected identical and related peptides that reacted with the paired CSF IgGs from each patient. Highly sensitive phage-mediated immuno-PCR revealed that the phage peptides bound specifically to IgG in MS CSF collected over time. IEF immunoblots also showed that these peptides were recognized by OCBs in MS CSF. We further demonstrated that the peptides represented linear epitopes, indicating that they represent natural epitopes of corresponding protein antigens. A database search combined with alanine scan mutagenesis of peptides that bound to CSF IgG from 3 MS patients revealed that they are derived from proteins including serine/threonine-protein kinase, protein ZIP2 and MHC class II. Identification of epitopes that are recognized by IgG in MS CSF over time provides a critical tool to investigate the specificity of OCBs, which may determine the cause of disease, leading to strategies for diagnostic and therapeutic intervention.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22079192      PMCID: PMC3278397          DOI: 10.1016/j.jneuroim.2011.10.009

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  24 in total

1.  Protective long-term antibody memory by antigen-driven and T help-dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organs.

Authors:  A F Ochsenbein; D D Pinschewer; S Sierro; E Horvath; H Hengartner; R M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

2.  Rapid and efficient identification of epitopes/mimotopes from random peptide libraries.

Authors:  Xiaoli Yu; Gregory P Owens; Donald H Gilden
Journal:  J Immunol Methods       Date:  2006-09-15       Impact factor: 2.303

3.  Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis.

Authors:  Birgit Obermeier; Reinhard Mentele; Joachim Malotka; Josef Kellermann; Tania Kümpfel; Hartmut Wekerle; Friedrich Lottspeich; Reinhard Hohlfeld; Klaus Dornmair
Journal:  Nat Med       Date:  2008-05-18       Impact factor: 53.440

4.  Laser-capture microdissection of plasma cells from subacute sclerosing panencephalitis brain reveals intrathecal disease-relevant antibodies.

Authors:  Mark P Burgoon; Kathryne M Keays; Gregory P Owens; Alanna M Ritchie; Pradeep R Rai; Carlyne D Cool; Donald H Gilden
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-09       Impact factor: 11.205

5.  Mapping protein-protein contact sites using cellulose-bound peptide scans.

Authors:  U Reineke; R Sabat; A Kramer; R D Stigler; M Seifert; T Michel; H D Volk; J Schneider-Mergener
Journal:  Mol Divers       Date:  1996-05       Impact factor: 2.943

6.  Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response.

Authors:  Marcus Odendahl; Henrik Mei; Bimba F Hoyer; Annett M Jacobi; Arne Hansen; Gwendolin Muehlinghaus; Claudia Berek; Falk Hiepe; Rudi Manz; Andreas Radbruch; Thomas Dörner
Journal:  Blood       Date:  2004-10-26       Impact factor: 22.113

7.  Relation between benign course of multiple sclerosis and low-grade humoral immune response in cerebrospinal fluid.

Authors:  L Stendahl-Brodin; H Link
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-02       Impact factor: 10.154

8.  Characterization of phage peptide interaction with antibody using phage mediated immuno-PCR.

Authors:  Xiaoli Yu; Mark P Burgoon; Andrew J Shearer; Donald H Gilden
Journal:  J Immunol Methods       Date:  2007-07-18       Impact factor: 2.303

9.  Expansion of antibody reactivity in the cerebrospinal fluid of multiple sclerosis patients - follow-up and clinical implications.

Authors:  Hela-Felicitas Petereit; Dirk Reske
Journal:  Cerebrospinal Fluid Res       Date:  2005-06-27

Review 10.  Infectious causes of multiple sclerosis.

Authors:  Donald H Gilden
Journal:  Lancet Neurol       Date:  2005-03       Impact factor: 44.182

View more
  13 in total

1.  Longitudinally persistent cerebrospinal fluid B cells can resist treatment in multiple sclerosis.

Authors:  Ariele L Greenfield; Ravi Dandekar; Akshaya Ramesh; Erica L Eggers; Hao Wu; Sarah Laurent; William Harkin; Natalie S Pierson; Martin S Weber; Roland G Henry; Antje Bischof; Bruce Ac Cree; Stephen L Hauser; Michael R Wilson; H-Christian von Büdingen
Journal:  JCI Insight       Date:  2019-03-21

2.  Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins.

Authors:  Simone M Brändle; Birgit Obermeier; Makbule Senel; Jessica Bruder; Reinhard Mentele; Mohsen Khademi; Tomas Olsson; Hayrettin Tumani; Wolfgang Kristoferitsch; Friedrich Lottspeich; Hartmut Wekerle; Reinhard Hohlfeld; Klaus Dornmair
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-20       Impact factor: 11.205

Review 3.  B-cell Therapy for Multiple Sclerosis: Entering an era.

Authors:  Ariele L Greenfield; Stephen L Hauser
Journal:  Ann Neurol       Date:  2018-01       Impact factor: 10.422

Review 4.  Intrathecal IgG synthesis: a resistant and valuable target for future multiple sclerosis treatments.

Authors:  Mickael Bonnan
Journal:  Mult Scler Int       Date:  2015-01-08

5.  A Distinct Class of Antibodies May Be an Indicator of Gray Matter Autoimmunity in Early and Established Relapsing Remitting Multiple Sclerosis Patients.

Authors:  Ann J Ligocki; Jacqueline R Rivas; William H Rounds; Alyssa A Guzman; Min Li; Melania Spadaro; Lauren Lahey; Ding Chen; Paul M Henson; Donna Graves; Benjamin M Greenberg; Elliot M Frohman; E Sally Ward; William Robinson; Edgar Meinl; Charles L White; Ann M Stowe; Nancy L Monson
Journal:  ASN Neuro       Date:  2015-10-21       Impact factor: 4.146

6.  BAFF Index and CXCL13 levels in the cerebrospinal fluid associate respectively with intrathecal IgG synthesis and cortical atrophy in multiple sclerosis at clinical onset.

Authors:  M Puthenparampil; L Federle; S Miante; A Zito; E Toffanin; S Ruggero; M Ermani; S Pravato; D Poggiali; P Perini; F Rinaldi; P Gallo
Journal:  J Neuroinflammation       Date:  2017-01-17       Impact factor: 8.322

7.  The chronically inflamed central nervous system provides niches for long-lived plasma cells.

Authors:  Karolin Pollok; Ronja Mothes; Carolin Ulbricht; Alina Liebheit; Jan David Gerken; Sylvia Uhlmann; Friedemann Paul; Raluca Niesner; Helena Radbruch; Anja Erika Hauser
Journal:  Acta Neuropathol Commun       Date:  2017-11-25       Impact factor: 7.801

Review 8.  Multiple sclerosis: an example of pathogenic viral interaction?

Authors:  Walter Fierz
Journal:  Virol J       Date:  2017-02-28       Impact factor: 4.099

Review 9.  New horizons for multiple sclerosis therapeutics: milestones in the development of ocrelizumab.

Authors:  Jessica Frau; Giancarlo Coghe; Lorena Lorefice; Giuseppe Fenu; Eleonora Cocco
Journal:  Neuropsychiatr Dis Treat       Date:  2018-04-23       Impact factor: 2.570

10.  Antibodies from Multiple Sclerosis Brain Identified Epstein-Barr Virus Nuclear Antigen 1 & 2 Epitopes which Are Recognized by Oligoclonal Bands.

Authors:  Michael W Graner; Xiaoli Yu; Zhe Wang; Peter Ge Kennedy; Cecily Dupree; Min Wang; Catherin Lee; Tiffany Pointon; T Dianne Langford
Journal:  J Neuroimmune Pharmacol       Date:  2020-08-18       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.